Compare Merck & Co., Inc. (MRK) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Tyson Foods, Inc. — how do they compare? Merck & Co., Inc. trades at $145.6 (market cap $351.28B), while Tyson Foods, Inc. trades at $53.43 (market cap $18.41B). The key difference: Merck & Co., Inc. is far larger — about 19.1× Tyson Foods, Inc.'s market cap, and Tyson Foods, Inc. pays the higher dividend (3.9%). Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Tyson Foods, Inc. for 76 Days on average.
| MRK | TSN | |
|---|---|---|
Market Cap | $351.28B | $18.41B |
Volume | 7,969,665 | 3,757,599 |
Sector | Health | Consumer Staples |
52-Week High | $156.43 | $68.75 |
52-Week Low | $82.49 | $50.47 |
Typical Hold Time | 98 Days | 76 Days |
Enterprise Value | $398.04B | $25.68B |
Dividend Yield | 2.39% | 3.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.40, down 0.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $65.01 billion in 2025, and net income reached $18.25 billion. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, with institutional investors increasing stakes.
The outlook for Merck is supported by analyst consensus with a $158.78 price target and 68% buy ratings, but risks include high valuation multiples like a P/E of 113.9 and competitive pressures in the pharma sector. The stock's investment appeal hinges on pipeline execution and integration of acquisitions amid a challenging technical backdrop.
Tyson Foods (TSN) trades at $52.34, up 1.24% on the day, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported revenue of $54.44 billion in 2025, with a net income margin of 1.03%, while recent earnings show two beats and one miss. Analysts maintain a consensus buy rating with a $65.40 price target, but news highlights challenges in the beef segment and ongoing securities investigations.
The outlook for TSN is cautiously optimistic, supported by analyst confidence and dividend stability, but risks include margin pressure from beef losses, legal scrutiny, and volatile cash flows. The stock's valuation at a P/E of 32.31 appears elevated relative to modest profitability, requiring careful monitoring of execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
